AIM ImmunoTech Inc (NYSE American:AIM)
| 0.5951 Delayed Data As of Jan 26 |  +0.0049 / +0.83%Today’s Change | 0.29 Today|||52-Week Range 1.38 | +90.80% Year-to-Date |
Latest AIM News | Press Releases
No recent news for AIM ImmunoTech Inc.
Today’s Trading
| Previous close | 0.59 |
| Today’s open | 0.61 |
| Day’s range | 0.58 - 0.61 |
| Volume | 270 |
| Average volume (3 months) | 211,977 |
| Market cap | $31.4M |
Data as of 3:57pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +10.66% |
| Earnings growth (this year) | -5.83% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -17.18% |
| P/E ratio | NM |
| Price/Sales | 322.61 |
| Price/Book | 0.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LUMOLumos Pharma Inc | -0.01 | -0.28% |
| SIOXSio Gene Therapies I... | +0.00 | +0.71% |
| PPBTPurple Biotech Ltd | -0.01 | -0.56% |
| ADMPAdamis Pharmaceutica... | -0.00 | -1.21% |
Data as of 3:59pm ET, 01/26/2023
Financials
| Next reporting date | March 30, 2023 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $135.0K |
| Annual profit (last year) | -$19.1M |
| Net profit margin | -14,168.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Ocala, Florida |
Forecasts
